T1	tradename 115 121	TRICOR
T3	tradename 183 190	TRICOR.
T5	tradename 202 208	TRICOR
T7	nanoparticle 210 222	fenofibrate)
T9	routeofadministration 235 239	oral
T11	fdaapprovaldate 267 271	1993
T13	tradename 380 386	TRICOR
T15	indication 593 613	hypercholesterolemia
T17	indication 623 635	dyslipidemia
T19	indication 709 729	hypertriglyceridemia
T21	nanoparticle 778 789	Fenofibrate
T23	indication 1019 1039	hypercholesterolemia
T25	indication 1049 1062	dyslipidemia:
T27	dose 1079 1085	160 mg
T29	frequency 1086 1096	once daily
T31	indication 1122 1143	hypertriglyceridemia:
T33	dose 1160 1172	54 to 160 mg
T35	frequency 1173 1184	once daily.
T37	dose 1212 1218	160 mg
T39	dose 1279 1284	54 mg
T41	frequency 1285 1295	once daily
T43	routeofadministration 1534 1538	Oral
T45	nanoparticle 1880 1891	fenofibrate
T47	adversereaction 2026 2034	Myopathy
T49	adversereaction 2039 2053	rhabdomyolysis
T51	nanoparticle 2092 2104	fenofibrate.
T53	adversereaction 2130 2138	myopathy
T55	adversereaction 2143 2157	rhabdomyolysis
T57	co-administereddrug 2213 2219	statin
T59	tradename 2404 2410	TRICOR
T61	adversereaction 2415 2444	increase serum transaminases.
T63	tradename 2538 2544	TRICOR
T65	adversereaction 2560 2592	increase serum creatinine levels
T67	tradename 2688 2694	TRICOR
T69	adversereaction 2761 2776	cholelithiasis.
T71	adversereaction 2791 2805	cholelithiasis
T73	routeofadministration 2919 2923	oral
T75	co-administereddrug 2924 2948	coumarin anticoagulants.
T77	co-administereddrug 2981 3003	coumarin anticoagulant
T79	adversereaction 3298 3318	abnormal liver tests
T81	adversereaction 3320 3333	increased AST
T83	adversereaction 3335 3348	increased ALT
T85	adversereaction 3350 3363	increased CPK
T87	adversereaction 3369 3377	rhinitis
T89	company 3452 3463	AbbVie Inc.
T91	co-administereddrug 3641 3665	Coumarin anticoagulants:
T93	co-administereddrug 3684 3703	Immunosuppressants:
T95	co-administereddrug 3722 3739	Bile acid resins:
T97	indication 4297 4317	Hypercholesterolemia
T99	indication 4327 4339	Dyslipidemia
T101	indication 4362 4382	Hypertriglyceridemia
T103	indication 4537 4557	Hypercholesterolemia
T105	indication 4567 4579	Dyslipidemia
T107	indication 4602 4622	Hypertriglyceridemia
T109	indication 6222 6242	Hypercholesterolemia
T111	indication 6293 6305	Dyslipidemia
T113	indication 6328 6348	Hypertriglyceridemia
T115	indication 6660 6680	Hypercholesterolemia
T117	indication 6690 6702	Dyslipidemia
T119	tradename 6714 6720	TRICOR
T121	indication 6993 7013	hypercholesterolemia
T123	indication 7023 7036	dyslipidemia.
T125	indication 7070 7090	Hypertriglyceridemia
T127	tradename 7102 7108	TRICOR
T129	indication 7201 7222	hypertriglyceridemia.
T131	nanoparticle 7523 7534	fenofibrate
T133	nanoparticle 7664 7675	Fenofibrate
T135	dose 7700 7706	160 mg
T137	tradename 7710 7716	TRICOR
T139	tradename 8099 8105	TRICOR
T141	tradename 8159 8173	TRICOR. TRICOR
T143	indication 8316 8328	dyslipidemia
T145	indication 8484 8504	hypertriglyceridemia
T147	indication 8938 8959	hypertriglyceridemia.
T149	indication 9084 9105	hypertriglyceridemia.
T151	tradename 9234 9240	TRICOR
T153	dose 9457 9463	160 mg
T155	frequency 9464 9475	once daily.
T157	indication 9510 9530	Hypercholesterolemia
T159	indication 9540 9552	Dyslipidemia
T161	tradename 9584 9590	TRICOR
T163	dose 9594 9600	160 mg
T165	frequency 9601 9612	once daily.
T167	indication 9646 9666	Hypertriglyceridemia
T169	dose 9698 9710	54 to 160 mg
T171	frequency 9711 9719	per day.
T173	dose 9925 9931	160 mg
T175	frequency 9932 9943	once daily.
T177	tradename 10020 10026	TRICOR
T179	dose 10060 10065	54 mg
T181	frequency 10066 10073	per day
T183	tradename 10259 10265	TRICOR
T185	tradename 10874 10880	TRICOR
T187	adversereaction 11109 11118	cirrhosis
T189	nanoparticle 11426 11437	fenofibrate
T191	activeingredient 11441 11456	fenofibric acid
T193	tradename 11642 11648	TRICOR
T195	nanoparticle 11992 12004	fenofibrate.
T197	nanoparticle 12062 12073	Fenofibrate
T199	co-administereddrug 12079 12085	statin
T201	nanoparticle 12808 12819	Fenofibrate
T203	nanoparticle 12988 13012	fenofibrate. Fenofibrate
T205	nanoparticle 13489 13500	fenofibrate
T207	tradename 13619 13625	TRICOR
T209	nanoparticle 13627 13638	fenofibrate
T211	tradename 13807 13814	TRICOR.
T213	adversereaction 16452 16460	myopathy
T215	adversereaction 16491 16506	rhabdomyolysis.
T217	adversereaction 16539 16554	muscle toxicity
T219	adversereaction 16692 16700	Myopathy
T221	tradename 17105 17111	TRICOR
T223	co-administereddrug 17408 17445	HMG-CoA reductase inhibitor (statin).
T225	adversereaction 17682 17690	myopathy
T227	adversereaction 17702 17716	rhabdomyolysis
T229	nanoparticle 17742 17754	fenofibrates
T231	co-administereddrug 17776 17786	colchicine
T233	nanoparticle 17837 17848	fenofibrate
T235	co-administereddrug 17854 17864	colchicine
T237	nanoparticle 17948 17959	Fenofibrate
T239	dose 17983 17989	107 mg
T241	dose 17993 17999	160 mg
T243	tradename 18000 18006	TRICOR
T245	frequency 18007 18014	per day
T247	adversereaction 18040 18072	increases in serum transaminases
T249	nanoparticle 18243 18254	fenofibrate
T251	adversereaction 18519 18545	increases in transaminases
T253	nanoparticle 18557 18568	fenofibrate
T255	dose 18789 18795	107 mg
T257	dose 18799 18805	160 mg
T259	tradename 18806 18812	TRICOR
T261	frequency 18813 18820	per day
T263	dose 18873 18878	54 mg
T265	tradename 18887 18893	TRICOR
T267	frequency 18894 18901	per day
T269	nanoparticle 18999 19010	fenofibrate
T271	adversereaction 19106 19115	cirrhosis
T273	tradename 19342 19348	TRICOR
T275	adversereaction 19490 19520	Elevations in serum creatinine
T277	nanoparticle 19555 19567	fenofibrate.
T279	nanoparticle 19641 19653	fenofibrate.
T281	tradename 19789 19796	TRICOR.
T283	tradename 19871 19877	TRICOR
T285	adversereaction 19984 19998	Cholelithiasis
T287	nanoparticle 20010 20021	Fenofibrate
T289	adversereaction 20117 20132	cholelithiasis.
T291	adversereaction 20147 20161	cholelithiasis
T293	tradename 20222 20228	TRICOR
T295	co-administereddrug 20311 20334	Coumarin Anticoagulants
T297	co-administereddrug 20379 20402	coumarin anticoagulants
T299	tradename 20433 20439	TRICOR
T301	co-administereddrug 20471 20498	coumarin-type anticoagulant
T303	adversereaction 20801 20813	Pancreatitis
T305	adversereaction 20825 20837	Pancreatitis
T307	nanoparticle 20875 20886	fenofibrate
T309	indication 21004 21024	hypertriglyceridemia
T311	nanoparticle 21357 21368	fenofibrate
T313	adversereaction 21465 21481	Thrombocytopenia
T315	adversereaction 21486 21501	agranulocytosis
T317	nanoparticle 21549 21561	fenofibrate.
T319	tradename 21674 21680	TRICOR
T321	adversereaction 21723 21749	Hypersensitivity Reactions
T323	adversereaction 21767 21793	hypersensitivity reactions
T325	adversereaction 21802 21826	Stevens-Johnson syndrome
T327	adversereaction 21831 21857	toxic epidermal necrolysis
T329	nanoparticle 21967 21979	fenofibrates
T331	adversereaction 21992 22001	Urticaria
T333	adversereaction 22030 22034	rash
T335	nanoparticle 22054 22065	fenofibrate
T337	nanoparticle 22298 22310	fenofibrate-
T339	nanoparticle 22446 22457	fenofibrate
T341	nanoparticle 22551 22562	fenofibrate
T343	nanoparticle 22662 22673	fenofibrate
T345	nanoparticle 24440 24451	fenofibrate
T347	nanoparticle 24680 24691	fenofibrate
T349	nanoparticle 24829 24840	fenofibrate
T351	nanoparticle 24992 25003	Fenofibrate
T353	nanoparticle 25091 25103	Fenofibrate*
T355	adversereaction 25173 25187	Abdominal Pain
T357	adversereaction 25198 25207	Back Pain
T359	adversereaction 25218 25226	Headache
T361	adversereaction 25247 25253	Nausea
T363	adversereaction 25264 25276	Constipation
T365	adversereaction 25323 25352	Abnormal Liver Function Tests
T367	adversereaction 25365 25378	Increased ALT
T369	adversereaction 25389 25402	Increased CPK
T371	adversereaction 25413 25426	Increased AST
T373	adversereaction 25451 25471	Respiratory Disorder
T375	adversereaction 25482 25490	Rhinitis
T377	dose 25524 25530	160 mg
T379	tradename 25531 25538	TRICOR.
T381	nanoparticle 25722 25734	fenofibrate:
T383	adversereaction 25735 25742	myalgia
T385	adversereaction 25744 25758	rhabdomyolysis
T387	adversereaction 25760 25772	pancreatitis
T389	adversereaction 25774 25793	acute renal failure
T391	adversereaction 25795 25807	muscle spasm
T393	adversereaction 25809 25818	hepatitis
T395	adversereaction 25820 25829	cirrhosis
T397	adversereaction 25831 25837	anemia
T399	adversereaction 25839 25849	arthralgia
T401	adversereaction 25851 25874	decreases in hemoglobin
T403	adversereaction 25876 25899	decreases in hematocrit
T405	adversereaction 25901 25927	white blood cell decreases
T407	adversereaction 25929 25937	asthenia
T409	adversereaction 25943 25985	severely depressed HDL-cholesterol levels.
T411	co-administereddrug 26267 26290	Coumarin Anticoagulants
T413	co-administereddrug 26318 26345	coumarin-type anticoagulant
T415	co-administereddrug 26449 26472	coumarin anticoagulants
T417	tradename 26503 26510	TRICOR.
T419	co-administereddrug 26843 26861	Immunosuppressants
T421	co-administereddrug 26873 26890	Immunosuppessants
T423	co-administereddrug 26899 26911	cyclosporine
T425	co-administereddrug 26916 26926	tacrolimus
T427	adversereaction 26939 26953	nephrotoxicity
T429	tradename 27112 27118	TRICOR
T431	tradename 27245 27251	TRICOR
T433	nanoparticle 27253 27264	fenofibrate
T435	co-administereddrug 27279 27297	immunosuppressants
T437	co-administereddrug 27466 27490	Bile Acid Binding Resins
T439	co-administereddrug 27508 27532	bile acid binding resins
T441	tradename 27595 27601	TRICOR
T443	co-administereddrug 27649 27672	bile acid binding resin
T445	co-administereddrug 27733 27743	Colchicine
T447	adversereaction 27764 27772	myopathy
T449	adversereaction 27784 27798	rhabdomyolysis
T451	nanoparticle 27824 27836	fenofibrates
T453	co-administereddrug 27858 27868	colchicine
T455	nanoparticle 27919 27930	fenofibrate
T457	co-administereddrug 27936 27947	colchicine.
T459	nanoparticle 28194 28205	fenofibrate
T461	nanoparticle 28236 28247	Fenofibrate
T463	routeofadministration 28396 28400	oral
T465	dose 28418 28420	15
T467	dose 28422 28424	75
T469	dose 28426 28439	and 300 mg/kg
T471	frequency 28439 28443	/day
T473	nanoparticle 28447 28458	fenofibrate
T475	routeofadministration 28651 28655	oral
T477	dose 28673 28675	14
T479	dose 28677 28680	127
T481	dose 28682 28696	and 361 mg/kg/
T483	frequency 28696 28699	day
T485	dose 28812 28821	14 mg/kg/
T487	frequency 28821 28824	day
T489	routeofadministration 29029 29033	oral
T491	dose 29050 29052	15
T493	dose 29054 29057	150
T495	dose 29059 29072	and 300 mg/kg
T497	frequency 29072 29076	/day
T499	dose 29193 29202	150 mg/kg
T501	frequency 29202 29206	/day
T503	routeofadministration 29467 29471	oral
T505	dose 29489 29491	15
T507	dose 29493 29495	75
T509	dose 29497 29510	and 300 mg/kg
T511	frequency 29510 29514	/day
T513	nanoparticle 29769 29780	Fenofibrate
T515	activeingredient 30154 30169	Fenofibric acid
T517	activeingredient 30338 30353	Fenofibric acid
T519	tradename 30783 30790	TRICOR.
T521	tradename 30856 30862	TRICOR
T523	tradename 31270 31276	TRICOR
T525	tradename 31494 31501	TRICOR.
T527	activeingredient 31848 31863	fenofibric acid
T529	tradename 31987 31993	TRICOR
T531	nanoparticle 31995 32006	fenofibrate
T533	routeofadministration 32070 32074	oral
T535	nanoparticle 32142 32154	fenofibrate.
T537	nanoparticle 32177 32188	fenofibrate
T539	molecularweight 32383 32389	360.83
T541	nanoparticle 32391 32402	fenofibrate
T543	nanoparticle 32477 32488	Fenofibrate
T545	inactiveingredient 32624 32649	colloidal silicon dioxide
T547	inactiveingredient 32651 32663	crospovidone
T549	inactiveingredient 32665 32684	lactose monohydrate
T551	inactiveingredient 32686 32694	lecithin
T553	inactiveingredient 32696 32722	microcrystalline cellulose
T555	inactiveingredient 32724 32741	polyvinyl alcohol
T557	inactiveingredient 32743 32751	povidone
T559	inactiveingredient 32753 32774	sodium lauryl sulfate
T561	inactiveingredient 32776 32799	sodium stearyl fumarate
T563	inactiveingredient 32801 32805	talc
T565	inactiveingredient 32807 32823	titanium dioxide
T567	inactiveingredient 32829 32841	xanthan gum.
T569	tradename 33093 33099	TRICOR
T571	activeingredient 33103 33119	fenofibric acid.
T573	activeingredient 33162 33177	fenofibric acid
T575	routeofadministration 33243 33247	oral
T577	nanoparticle 33266 33278	fenofibrate.
T579	activeingredient 33333 33348	fenofibric acid
T581	nanoparticle 33572 33583	fenofibrate
T583	nanoparticle 34289 34300	Fenofibrate
T585	activeingredient 35197 35212	Fenofibric acid
T587	nanoparticle 35239 35250	fenofibrate
T589	nanoparticle 35450 35461	fenofibrate
T591	nanoparticle 35610 35621	Fenofibrate
T593	activeingredient 35666 35682	fenofibric acid.
T595	nanoparticle 35683 35694	Fenofibrate
T597	activeingredient 35743 35758	fenofibric acid
T599	activeingredient 35891 35906	fenofibric acid
T601	nanoparticle 35984 35995	fenofibrate
T603	nanoparticle 36054 36065	fenofibrate
T605	nanoparticle 36249 36260	fenofibrate
T607	activeingredient 36262 36277	fenofibric acid
T609	activeingredient 36354 36369	fenofibric acid
T611	routeofadministration 36593 36597	oral
T613	nanoparticle 36614 36625	fenofibrate
T615	activeingredient 36687 36702	fenofibric acid
T617	nanoparticle 36717 36728	fenofibrate
T619	activeingredient 36763 36778	Fenofibric acid
T621	activeingredient 36881 36896	fenofibric acid
T623	nanoparticle 37100 37111	fenofibrate
T625	activeingredient 37116 37131	fenofibric acid
T627	nanoparticle 37273 37284	fenofibrate
T629	activeingredient 37355 37370	fenofibric acid
T631	activeingredient 37375 37390	fenofibric acid
T633	nanoparticle 37453 37464	fenofibrate
T635	activeingredient 37575 37590	Fenofibric acid
T637	eliminationhalflife 37625 37633	20 hours
T639	routeofadministration 37787 37791	oral
T641	activeingredient 37805 37820	fenofibric acid
T643	routeofadministration 37840 37844	oral
T645	nanoparticle 37853 37864	fenofibrate
T647	clearance 37869 37876	1.2 L/h
T649	clearance 37896 37903	1.1 L/h
T651	tradename 38232 38238	TRICOR
T653	nanoparticle 38404 38416	fenofibrate.
T655	nanoparticle 38504 38515	fenofibrate
T657	nanoparticle 38546 38557	fenofibrate
T659	activeingredient 38709 38724	fenofibric acid
T661	activeingredient 38958 38973	fenofibric acid
T663	activeingredient 39004 39019	fenofibric acid
T665	activeingredient 39224 39239	fenofibric acid
T667	tradename 39325 39331	TRICOR
T669	nanoparticle 39770 39781	fenofibrate
T671	activeingredient 39786 39801	fenofibric acid
T673	activeingredient 40121 40136	fenofibric acid
T675	nanoparticle 40216 40227	fenofibrate
T677	activeingredient 40231 40246	fenofibric acid
T679	activeingredient 40330 40345	Fenofibric Acid
T681	nanoparticle 40369 40380	Fenofibrate
T683	nanoparticle 40507 40519	Fenofibrate*
T685	activeingredient 40542 40557	Fenofibric Acid
T687	co-administereddrug 40620 40632	Atorvastatin
T689	dose 40633 40638	20 mg
T691	frequency 40639 40661	once daily for 10 days
T693	nanoparticle 40662 40673	Fenofibrate
T695	dose 40674 40681	160 mg1
T697	frequency 40682 40696	once daily for
T699	frequency 40708 40715	10 days
T701	co-administereddrug 40785 40796	Pravastatin
T703	dose 40797 40802	40 mg
T705	nanoparticle 40820 40831	Fenofibrate
T707	co-administereddrug 40940 40951	Fluvastatin
T709	dose 40952 40957	40 mg
T711	nanoparticle 40975 40986	Fenofibrate
T713	dose 40987 40994	160 mg1
T715	co-administereddrug 41125 41136	Glimepiride
T717	dose 41137 41141	1 mg
T719	nanoparticle 41159 41170	Fenofibrate
T721	dose 41171 41178	145 mg1
T723	frequency 41179 41193	once daily for
T725	frequency 41205 41212	10 days
T727	co-administereddrug 41282 41291	Metformin
T729	dose 41292 41298	850 mg
T731	frequency 41299 41328	three times daily for 10 days
T733	nanoparticle 41329 41340	Fenofibrate
T735	dose 41341 41347	54 mg1
T737	frequency 41348 41377	three times daily for 10 days
T739	co-administereddrug 41447 41460	Rosiglitazone
T741	dose 41461 41465	8 mg
T743	frequency 41466 41487	once daily for 5 days
T745	nanoparticle 41488 41499	Fenofibrate
T747	dose 41500 41507	145 mg1
T749	frequency 41508 41522	once daily for
T751	frequency 41534 41541	14 days
T753	activeingredient 41650 41665	fenofibric acid
T755	activeingredient 41827 41842	fenofibric acid
T757	dose 41871 41877	145 mg
T759	dose 41928 41934	200 mg
T761	tradename 41946 41952	TriCor
T763	nanoparticle 41954 41966	fenofibrate)
T765	routeofadministration 41967 41971	oral
T767	tradename 41981 41987	TriCor
T769	nanoparticle 41989 42001	fenofibrate)
T771	routeofadministration 42002 42006	oral
T773	nanoparticle 42057 42068	Fenofibrate
T775	nanoparticle 42152 42164	Fenofibrate*
T777	nanoparticle 42289 42300	Fenofibrate
T779	dose 42301 42308	160 mg1
T781	frequency 42309 42331	once daily for 10 days
T783	co-administereddrug 42343 42355	Atorvastatin
T785	dose 42357 42362	20 mg
T787	frequency 42363 42385	once daily for 10 days
T789	co-administereddrug 42386 42398	Atorvastatin
T791	nanoparticle 42440 42451	Fenofibrate
T793	co-administereddrug 42480 42491	Pravastatin
T795	dose 42493 42498	40 mg
T797	co-administereddrug 42516 42527	Pravastatin
T799	nanoparticle 42761 42772	Fenofibrate
T801	dose 42773 42780	160 mg1
T803	co-administereddrug 42798 42809	Fluvastatin
T805	dose 42811 42816	40 mg
T807	co-administereddrug 42842 42856	5S-Fluvastatin
T809	nanoparticle 42960 42971	Fenofibrate
T811	dose 42972 42979	145 mg1
T813	frequency 42980 43002	once daily for 10 days
T815	co-administereddrug 43003 43014	Glimepiride
T817	dose 43016 43020	1 mg
T819	co-administereddrug 43038 43049	Glimepiride
T821	nanoparticle 43121 43132	Fenofibrate
T823	dose 43133 43139	54 mg1
T825	frequency 43140 43169	three times daily for 10 days
T827	co-administereddrug 43181 43190	Metformin
T829	dose 43192 43198	850 mg
T831	frequency 43199 43228	three times daily for 10 days
T833	co-administereddrug 43229 43238	Metformin
T835	nanoparticle 43308 43319	Fenofibrate
T837	dose 43320 43327	145 mg1
T839	frequency 43328 43350	once daily for 14 days
T841	co-administereddrug 43362 43375	Rosiglitazone
T843	dose 43377 43381	8 mg
T845	frequency 43382 43403	once daily for 5 days
T847	co-administereddrug 43404 43417	Rosiglitazone
T849	activeingredient 43525 43540	fenofibric acid
T851	activeingredient 43692 43707	fenofibric acid
T853	dose 43736 43742	145 mg
T855	dose 43793 43799	200 mg
T857	tradename 43822 43828	TriCor
T859	nanoparticle 43830 43842	fenofibrate)
T861	routeofadministration 43843 43847	oral
T863	tradename 43857 43863	TriCor
T865	nanoparticle 43865 43877	fenofibrate)
T867	routeofadministration 43878 43882	oral
T869	nanoparticle 44105 44117	fenofibrate.
T871	nanoparticle 44185 44196	fenofibrate
T873	dose 44200 44202	10
T875	dose 44204 44206	45
T877	dose 44208 44222	and 200 mg/kg/
T879	frequency 44222 44225	day
T881	dose 44376 44386	200 mg/kg/
T883	frequency 44386 44389	day
T885	dose 44852 44868	10 and 60 mg/kg/
T887	frequency 44868 44871	day
T889	nanoparticle 45174 45185	fenofibrate
T891	dose 45186 45202	10 and 60 mg/kg/
T893	frequency 45202 45205	day
T895	dose 45246 45256	400 mg/kg/
T897	frequency 45256 45259	day
T899	dose 45303 45313	250 mg/kg/
T901	frequency 45313 45316	day
T903	nanoparticle 45383 45394	Fenofibrate
T905	nanoparticle 45803 45814	fenofibrate
T907	dose 45815 45817	10
T909	dose 45819 45821	45
T911	dose 45823 45836	and 200 mg/kg
T913	frequency 45836 45840	/day
T915	frequency 46063 46067	/day
T917	nanoparticle 46069 46080	fenofibrate
T919	nanoparticle 46298 46309	fenofibrate
T921	nanoparticle 46686 46697	Fenofibrate
T923	routeofadministration 46967 46971	oral
T925	nanoparticle 46989 47000	fenofibrate
T927	dose 47157 47166	300 mg/kg
T929	frequency 47166 47170	/day
T931	indication 47300 47320	Hypercholesterolemia
T933	indication 47371 47383	Dyslipidemia
T935	nanoparticle 47410 47421	fenofibrate
T937	dose 47446 47452	160 mg
T939	tradename 47453 47459	TRICOR
T941	nanoparticle 47461 47472	fenofibrate
T943	tradename 47738 47744	TRICOR
T945	tradename 47815 47821	TRICOR
T947	tradename 48860 48866	TRICOR
T949	indication 49052 49072	Hypertriglyceridemia
T951	nanoparticle 49099 49110	fenofibrate
T953	indication 49485 49505	hypertriglyceridemia
T955	nanoparticle 49586 49597	fenofibrate
T957	tradename 49623 49629	TRICOR
T959	dose 49630 49636	160 mg
T961	frequency 49637 49644	per day
T963	tradename 49893 49899	TRICOR
T965	indication 49924 49944	Hypertriglyceridemia
T967	tradename 49961 49967	TRICOR
T969	tradename 50404 50410	TRICOR
T971	tradename 50904 50910	TRICOR
T973	tradename 51048 51054	TRICOR
T975	nanoparticle 51056 51067	fenofibrate
T977	tradename 51744 51751	TRICOR.
T979	tradename 51774 51780	TRICOR
T981	nanoparticle 51821 51832	fenofibrate
T983	activeingredient 51836 51852	fenofibric acid.
T985	tradename 51924 51931	TRICOR.
T987	tradename 51992 51998	TRICOR
T989	tradename 52166 52173	TRICOR.
T991	tradename 52193 52199	TRICOR
T993	tradename 52597 52604	TRICOR.
T995	company 52767 52778	AbbVie Inc.
T997	company 52815 52836	Laboratoires Fournier
T999	company 52838 52842	S.A.
